FDA advisers to weigh composition of COVID vaccines for 2026-2027

By Christy Santhosh May 28 (Reuters) - The U.S. FDA's advisory panel will vote on Thursday on whether COVID-19 vaccines for ...
Pharm Exec

FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant

VRBPAC is evaluating an XFG-targeted composition for 2026–2027 vaccines, based on CDC variant prevalence estimates that are more than a month old. FDA briefing materials emphasize eroding sequencing ...

FDA AdCom panel to review and vote on next COVID shots

An advisory panel of the U.S. Food and Drug Administration will meet this week to discuss and vote on the composition of the 2026–2027 formula for COVID shots to be used during the next immunization ...